Evidence map›Paper›PMID 27061806›Full record

ArticleRheumatology international2016

Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran.

Hadi Poormoghim, Elham Andalib, Arash Jalali, Afshin Ghaderi, Ali Ghorbannia, Nazanin Mojtabavi

Abstract read
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Rheumatology training and research in Iran.Rheumatology international · 2019
    Pooled it
  2. Pooled it
  3. Automatic assessment of lung involvement in systemic sclerosis using deep learning.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2026
    Article
  4. Systemic sclerosis in Asians: Are there racial differences?Journal of scleroderma and related disorders · 2022
    Review
  5. Article
  6. Emerging Roles of Matricellular Proteins in Systemic Sclerosis.International journal of molecular sciences · 2020
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hadi PoormoghimScleroderma Study Group, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran. poormoghim.h@iums.ac.ir.
Elham AndalibScleroderma Study Group, Firoozgar Hospital, Tehran, Iran.
Arash JalaliDepartment of Epidemiology and Biostatistics, Tehran University of Medical Sciences, Tehran, Iran.
Afshin GhaderiScleroderma Study Group, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
Ali GhorbanniaScleroderma Study Group, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
Nazanin MojtabaviDepartment of Immunology, Iran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aims of the study were to determine prognostic factors for survival and causes of death in a cohort of patients with systemic sclerosis (SSc). This was a cohort study of SSc patients in single rheumatologic center from January 1998 to August 2012. They fulfilled the American College of Rheumatology classification criteria for SSc or had calcinosis Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, telangiectasia or sine sclerosis. Causes of death were classified as SSc related and non-SSc related. Kaplan-Meier and Cox proportional hazard regression models were used in univariate and multivariate analysis to analyse survival in subgroups and determine prognostic factors of survival. The study includes 220 patients (192 female, 28 male). Out of thirty-two (14.5 %) who died, seventeen (53.1 %) deaths were SSc related and in nine (28.1 %) non-SSc-related causes, and in six (18.8 %) of patients causes of death were not defined. Overall survival rate was 92.6 % (95 % CI 87.5-95.7 %) after 5 years and 82.3 % (95 % CI 73.4-88.4 %) after 10 years. Pulmonary involvement was a major SSc-related cause of death, occurred in seven (41.1 %) patients. Cardiovascular events were leading cause of in overall death (11) 34.3 % and 6 in non-SSc-related death. Independent risk factors for mortality were age >50 at diagnosis (HR 5.10) advance pulmonary fibrosis (HR 11.5), tendon friction rub at entry (HR 6.39), arthritis (HR 3.56). In this first Middle Eastern series of SSc registry, pulmonary and cardiac involvements were the leading cause of SSc-related death.

Indexed as

AdultCause of DeathChi-Square DistributionFemaleHeart DiseasesHumansIranKaplan-Meier EstimateLung DiseasesMaleMiddle AgedMultivariate AnalysisPrognosisProportional Hazards ModelsRegistriesRisk FactorsCauses of deathSurvivalSystemic sclerosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.